Sale!

MECP2 Gene Rett Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MECP2 Gene Rett Syndrome NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the MECP2 gene associated with Rett syndrome, a rare neurodevelopmental disorder primarily affecting females. Using next-generation sequencing (NGS) technology, this test provides highly accurate detection of genetic variations that cause developmental regression, loss of purposeful hand skills, and motor impairments. The test is essential for children showing symptoms of developmental delays, autistic features, or neurological regression. Benefits include early diagnosis, personalized treatment planning, genetic counseling guidance, and family planning insights. Available for $500 USD with genetic counseling included.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MECP2 Gene Rett Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Rett Syndrome Diagnosis

The MECP2 Gene Rett Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for neurodevelopmental disorders. This advanced test utilizes cutting-edge Next-Generation Sequencing (NGS) technology to detect mutations in the MECP2 gene, which is responsible for Rett syndrome—a rare but serious genetic condition primarily affecting females. Early and accurate diagnosis through this comprehensive genetic analysis enables timely intervention and personalized treatment strategies.

What Does the MECP2 Gene Rett Syndrome Test Measure?

This sophisticated genetic test specifically targets and analyzes the MECP2 gene located on the X chromosome. The test detects:

  • Point mutations and small deletions/insertions in the MECP2 gene
  • Large deletions and duplications affecting gene function
  • Specific genetic variants known to cause Rett syndrome
  • Novel mutations that may contribute to atypical presentations

Using NGS technology, the test achieves over 99% accuracy in detecting clinically relevant mutations, providing comprehensive coverage of all coding regions and critical regulatory elements of the MECP2 gene.

Who Should Consider This Genetic Test?

This test is recommended for individuals displaying symptoms suggestive of Rett syndrome or related neurodevelopmental disorders:

  • Female children showing developmental regression after initial normal development
  • Individuals with loss of purposeful hand skills and development of stereotypic hand movements
  • Children exhibiting gait abnormalities or loss of acquired motor skills
  • Patients with autistic features, breathing irregularities, or seizures
  • Individuals with family history of Rett syndrome or unexplained developmental disorders
  • Cases where traditional diagnostic methods have been inconclusive

Key Benefits of MECP2 Genetic Testing

  • Early and Accurate Diagnosis: Provides definitive genetic confirmation of Rett syndrome, enabling early intervention
  • Personalized Treatment Planning: Guides development of targeted therapeutic approaches based on specific genetic findings
  • Genetic Counseling Support: Helps families understand inheritance patterns and recurrence risks
  • Family Planning Guidance: Provides crucial information for future reproductive decisions
  • Comprehensive Clinical Correlation: Connects genetic findings with clinical symptoms for better management
  • Research Contribution: Contributes to ongoing research and understanding of Rett syndrome

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and medical geneticists:

  • Positive Result: Indicates the presence of a known pathogenic mutation in the MECP2 gene, confirming Rett syndrome diagnosis
  • Negative Result: No pathogenic mutations detected, though clinical correlation remains important
  • Variant of Uncertain Significance (VUS): Identifies genetic changes requiring further clinical correlation and family studies
  • Comprehensive Report: Includes detailed interpretation, clinical implications, and management recommendations

All results are accompanied by genetic counseling to ensure complete understanding and appropriate next steps.

Test Details and Pricing

Test Information Details
Test Name MECP2 Gene Rett Syndrome NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.

Take the Next Step Toward Diagnosis

If you suspect Rett syndrome or have concerns about developmental regression in your child, don’t wait to get answers. Our comprehensive MECP2 genetic testing provides the clarity needed for proper diagnosis and management. Schedule your test today and take advantage of our special discounted rate of $500 USD.

Call or WhatsApp us now at +1(267) 388-9828 to book your MECP2 Gene Rett Syndrome NGS Genetic DNA Test and receive expert genetic counseling.